1. Home
  2. ICUI vs TBBK Comparison

ICUI vs TBBK Comparison

Compare ICUI & TBBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICUI
  • TBBK
  • Stock Information
  • Founded
  • ICUI 1984
  • TBBK 1999
  • Country
  • ICUI United States
  • TBBK United States
  • Employees
  • ICUI N/A
  • TBBK N/A
  • Industry
  • ICUI Medical/Dental Instruments
  • TBBK Major Banks
  • Sector
  • ICUI Health Care
  • TBBK Finance
  • Exchange
  • ICUI Nasdaq
  • TBBK Nasdaq
  • Market Cap
  • ICUI 3.4B
  • TBBK 3.0B
  • IPO Year
  • ICUI 1992
  • TBBK 2004
  • Fundamental
  • Price
  • ICUI $127.40
  • TBBK $62.49
  • Analyst Decision
  • ICUI Strong Buy
  • TBBK Buy
  • Analyst Count
  • ICUI 5
  • TBBK 3
  • Target Price
  • ICUI $196.75
  • TBBK $65.33
  • AVG Volume (30 Days)
  • ICUI 186.2K
  • TBBK 941.0K
  • Earning Date
  • ICUI 08-07-2025
  • TBBK 07-24-2025
  • Dividend Yield
  • ICUI N/A
  • TBBK N/A
  • EPS Growth
  • ICUI N/A
  • TBBK 21.30
  • EPS
  • ICUI N/A
  • TBBK 4.65
  • Revenue
  • ICUI $2,420,093,000.00
  • TBBK $515,889,000.00
  • Revenue This Year
  • ICUI N/A
  • TBBK N/A
  • Revenue Next Year
  • ICUI N/A
  • TBBK $23.36
  • P/E Ratio
  • ICUI N/A
  • TBBK $13.59
  • Revenue Growth
  • ICUI 7.22
  • TBBK 11.24
  • 52 Week Low
  • ICUI $117.92
  • TBBK $40.51
  • 52 Week High
  • ICUI $196.26
  • TBBK $70.63
  • Technical
  • Relative Strength Index (RSI)
  • ICUI 46.81
  • TBBK 49.07
  • Support Level
  • ICUI $124.39
  • TBBK $60.26
  • Resistance Level
  • ICUI $134.04
  • TBBK $65.59
  • Average True Range (ATR)
  • ICUI 3.75
  • TBBK 2.65
  • MACD
  • ICUI 0.18
  • TBBK -1.03
  • Stochastic Oscillator
  • ICUI 47.55
  • TBBK 26.67

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.

About TBBK The Bancorp Inc

The Bancorp Inc is a financial holding company. The Company's operations are classified under three segments: fintech, specialty finance (three sub-segments), and corporate. The fintech segment includes the deposit balances and non-interest income generated by prepaid, debit, and other card-accessed accounts, ACH processing, and other payments-related processing. It also includes loan balances and interest and non-interest income from credit products generated through payment relationships; Specialty finance includes REBL (real estate bridge lending) comprised of apartment building rehabilitation loans, and Others; Corporate includes the Company's investment securities, corporate overhead, and expenses which have not been allocated to segments.

Share on Social Networks: